T43.602 Poisoning by unspecified psychostimulants, intentional self-harm

Name of the Condition

• Poisoning by unspecified psychostimulants, intentional self-harm

Summary

This condition involves the deliberate ingestion or exposure to psychostimulant substances with the intent to cause self-harm, resulting in toxic effects. Psychostimulants are drugs that increase alertness, attention, or energy, and "unspecified" indicates the specific type of stimulant is not identified. Intentional self-harm implies the exposure was deliberate.

Causes

Intentional self-harm poisoning can result from deliberate overdose, misuse, or self-administration of psychostimulants, which may include prescription medications, illicit drugs, or over-the-counter stimulants. The act is driven by suicidal intent or self-injurious behavior.

Risk Factors

• History of suicidal ideation or attempts.
• Mental health conditions such as depression, anxiety, or bipolar disorder.
• Substance use disorders involving psychostimulants.
• Access to psychostimulant medications or illicit stimulants.
• Recent stressors or crises that may trigger self-harm.

Symptoms

• Agitation, restlessness, or extreme anxiety.
• Tachycardia, hypertension, or irregular heartbeat.
• Tremors, muscle spasms, or seizures.
• Nausea, vomiting, or abdominal pain.
• Confusion, hallucinations, or altered mental status.
• Excessive sweating, fever, or hyperthermia.

Diagnosis

Diagnosis is based on patient history, clinical presentation, and toxicology screening. Documentation of intentional self-harm intent is critical. Physical examination and laboratory tests may assess organ function and identify the presence of psychostimulants or their metabolites.

Treatment Options

Treatment focuses on stabilizing the patient, managing symptoms, and addressing the underlying intent. This may include airway support, cardiovascular monitoring, and administration of antidotes or supportive care. Psychiatric evaluation and intervention are essential for long-term management.

Prognosis and Follow-Up

Prognosis depends on the severity of poisoning, timeliness of treatment, and underlying mental health status. Follow-up care involves ongoing psychiatric support, substance use counseling, and monitoring for recurrence of self-harm behaviors.

Complications

• Severe cardiovascular events (e.g., heart attack, stroke).
• Neurological damage (e.g., seizures, coma).
• Organ failure (e.g., liver, kidney).
• Long-term psychiatric or cognitive impairment.
• Risk of recurrent self-harm or suicide.

Lifestyle & Prevention

• Secure storage of psychostimulant medications to prevent access.
• Education on the risks of stimulant misuse and self-harm.
• Regular mental health check-ins for at-risk individuals.
• Encouragement of healthy coping mechanisms and support networks.

When to Seek Professional Help

Seek immediate medical attention if self-harm with psychostimulants is suspected or if symptoms of poisoning (e.g., severe agitation, chest pain, seizures) occur. Prompt care is critical to prevent life-threatening complications.

Tips for Medical Coders

Document the intent of self-harm clearly in the medical record, as this distinguishes the code from accidental or undetermined poisoning. Ensure the unspecified nature of the psychostimulant is noted, and verify that the encounter aligns with the intentional self-harm context.